protocolSection identificationModule nctId: NCT06275971, orgStudyIdInfo id: KBSMC 2022-07-006, briefTitle: Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-11-24, primaryCompletionDateStruct date: 2024-06-30, completionDateStruct date: 2024-08-31, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-23, sponsorCollaboratorsModule leadSponsor name: Kangbuk Samsung Hospital, class: OTHER, collaborators name: DexCom, Inc., descriptionModule briefSummary: The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post-surgery when Continuous Glucose Monitoring (CGM) is utilized, as compared to traditional methods of arterial/venous blood sampling and Point-of-Care Testing (POCT) for glucose monitoring., conditionsModule conditions: Cardiac Disease, conditions: PreDiabetes, conditions: Diabetes Mellitus, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Treatment group: glycemic control using CGM Control group: glycemic control using arterial/venous blood sampling and POCT glucose, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 68, type: ESTIMATED, armsInterventionsModule interventions name: Dexcom G6, interventions name: SMBG or venous/arterial blood glucose, outcomesModule primaryOutcomes measure: Time within the target range of 100-180 mg/dL, secondaryOutcomes measure: Time within the target range of 100-140 mg/dL, secondaryOutcomes measure: Time within the target range of 70-180 mg/dL, secondaryOutcomes measure: Time to reach <70 mg/dL, secondaryOutcomes measure: Time to reach <54 mg/dL, secondaryOutcomes measure: Time to reach >180 mg/dL, secondaryOutcomes measure: Time to reach >250 mg/dL, secondaryOutcomes measure: Standard Deviation (SD), secondaryOutcomes measure: Coefficient of variation (CV), secondaryOutcomes measure: Mean glucose, secondaryOutcomes measure: Glucose management indicator (GMI), secondaryOutcomes measure: Number of days of ICU hospitalization, secondaryOutcomes measure: Number of days hospitalized after surgery, secondaryOutcomes measure: Number of participants with pneumonia occurrence after surgery, secondaryOutcomes measure: Number of participants with wound infection occurrence after surgery, secondaryOutcomes measure: Number of participants who underwent CRRT implementation after surgery, secondaryOutcomes measure: Number of participants with Atrial fibrillation occurrence after surgery, secondaryOutcomes measure: Number of participants with symptomatic CVA (ischemic and hemorrhagic) occurrence after surgery, secondaryOutcomes measure: Changes in concentration of serum CRP level after surgery, secondaryOutcomes measure: Mortality within 30 days of surgery, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Kangbuk Samsung Hospital, status: RECRUITING, city: Seoul, zip: 03181, country: Korea, Republic of, contacts name: Sun Joon Moon, MD, role: CONTACT, geoPoint lat: 37.566, lon: 126.9784, hasResults: False